The tariff classification of Levodopa (CAS-59-92-7) in dosage/tablet form, from India
Reasoning
The tariff classification of Levodopa (CAS-59-92-7) in dosage/tablet form, from India
Cite this ruling
CBP Ruling N025968 (3004909140): The tariff classification of Levodopa (CAS-59-92-7) in dosage/tablet form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Amazon Cigarette Repulsor from Brazil
Protest 3801-99-100280; Oxazolidinone 200 ml, Linezolid 2 mg/ml 100ml, and placebo for Linezolid 200 ml
Protest 1101-99-100114; SB-207499 and placebo capsules
Protest 1101-99-100129; SR-57746A and placebo capsules
lassified by application of GRI 1, that is, according to the terms of the headings of the tariff schedule and any relative Section or Chapter Notes. In the event that the goods cannot be classified solely on the basis of GRI 1, and if the headings and legal notes do not otherwise require, the remaining GRIs may then be applied in order.